BioCentury
ARTICLE | Clinical News

RO6885247: Phase Ib/IIa started

January 19, 2015 8:00 AM UTC

Roche began the double-blind, placebo-controlled, international Phase Ib/IIa MOONFISH trial to evaluate once-daily oral RG7800 for 12 weeks in about 48 patients ages 2-55. The start of the trial trigg...